Titlebook: Liver, Lung and Heart Regeneration; Phuc Van Pham Book 2017 The Editor(s) (if applicable) and The Author(s), under exclusive license to Sp

只看該作者 · 發(fā)表于 2025-3-25 18:50:26

Cell Therapy in Chronic Liver Diseaseis section, the pathogenesis of major liver injuries and the contribution of inflammatory cytokines to disease progression will be discussed. In the second section, we will describe current targeted therapies for chronic liver injuries. This will include the degradation of fibrosis, the downregulati

只看該作者 · 發(fā)表于 2025-3-25 22:02:10

Clinical Applications of Stem Cells in Liver Cirrhosisals were included in both English and non-English languages. The sporadic nature of the data across the trials, with various methods and stem cell types, made comparisons difficult. The basic trends from the data were positive and the majority deemed the use of stem cells safe and feasible in patien

只看該作者 · 發(fā)表于 2025-3-26 00:08:02

只看該作者 · 發(fā)表于 2025-3-26 07:28:56

只看該作者 · 發(fā)表于 2025-3-26 10:59:45

只看該作者 · 發(fā)表于 2025-3-26 14:11:13

只看該作者 · 發(fā)表于 2025-3-26 16:47:20

		自動登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點評	投稿經(jīng)驗總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 00:49
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved